These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8175161)
1. Oxidized lipoproteins inhibit endothelium-dependent vasodilation. Effects of pressure and high-density lipoprotein. Galle J; Ochslen M; Schollmeyer P; Wanner C Hypertension; 1994 May; 23(5):556-64. PubMed ID: 8175161 [TBL] [Abstract][Full Text] [Related]
2. Oxidized lipoprotein(a) inhibits endothelium-dependent dilation: prevention by high density lipoprotein. Galle J; Bengen J; Schollmeyer P; Wanner C Eur J Pharmacol; 1994 Nov; 265(1-2):111-5. PubMed ID: 7883023 [TBL] [Abstract][Full Text] [Related]
3. Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Role of oxygen-derived radicals. Galle J; Bengen J; Schollmeyer P; Wanner C Circulation; 1995 Sep; 92(6):1582-9. PubMed ID: 7664444 [TBL] [Abstract][Full Text] [Related]
4. High density lipoprotein and low density lipoprotein attenuate the inhibitory effects of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Matsuda Y Kobe J Med Sci; 1993 Feb; 39(1):1-14. PubMed ID: 8366661 [TBL] [Abstract][Full Text] [Related]
5. High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Matsuda Y; Hirata K; Inoue N; Suematsu M; Kawashima S; Akita H; Yokoyama M Circ Res; 1993 May; 72(5):1103-9. PubMed ID: 8477522 [TBL] [Abstract][Full Text] [Related]
6. Cyclosporine and oxidized lipoproteins affect vascular reactivity. Influence of the endothelium. Galle J; Schenck I; Schollmeyer P; Wanner C Hypertension; 1993 Mar; 21(3):315-21. PubMed ID: 8478041 [TBL] [Abstract][Full Text] [Related]
7. Effects of native and oxidized low-density lipoproteins on endothelium-dependent and endothelium-independent vasomotion. Galle J; Bassenge E Basic Res Cardiol; 1991; 86 Suppl 2():127-42. PubMed ID: 1953605 [TBL] [Abstract][Full Text] [Related]
8. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a). Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434 [TBL] [Abstract][Full Text] [Related]
9. Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: role of enhanced oxidative stress. Galle J; Schneider R; Winner B; Lehmann-Bodem C; Schinzel R; Münch G; Conzelmann E; Wanner C Atherosclerosis; 1998 May; 138(1):65-77. PubMed ID: 9678772 [TBL] [Abstract][Full Text] [Related]
10. Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Galle J; Mülsch A; Busse R; Bassenge E Arterioscler Thromb; 1991; 11(1):198-203. PubMed ID: 1987998 [TBL] [Abstract][Full Text] [Related]
11. oxLDL specifically impairs endothelium-dependent, NO-mediated dilation of coronary arterioles. Hein TW; Liao JC; Kuo L Am J Physiol Heart Circ Physiol; 2000 Jan; 278(1):H175-83. PubMed ID: 10644597 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of cyclic AMP- and cyclic GMP-mediated dilations in isolated arteries by oxidized low density lipoproteins. Galle J; Bauersachs J; Busse R; Bassenge E Arterioscler Thromb; 1992 Feb; 12(2):180-6. PubMed ID: 1311946 [TBL] [Abstract][Full Text] [Related]
13. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta. Plane F; Bruckdorfer KR; Kerr P; Steuer A; Jacobs M Br J Pharmacol; 1992 Jan; 105(1):216-22. PubMed ID: 1596684 [TBL] [Abstract][Full Text] [Related]
14. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Tanner FC; Noll G; Boulanger CM; Lüscher TF Circulation; 1991 Jun; 83(6):2012-20. PubMed ID: 2040054 [TBL] [Abstract][Full Text] [Related]
15. CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O(2)(-) formation. Galle J; Lehmann-Bodem C; Hübner U; Heinloth A; Wanner C Nephrol Dial Transplant; 2000 Mar; 15(3):339-46. PubMed ID: 10692519 [TBL] [Abstract][Full Text] [Related]
16. Cyclosporin and oxidized low density lipoproteins synergistically potentiate vasoconstriction: influence of the endothelium. Galle J; Schollmeyer P; Wanner C Eur Heart J; 1993 Nov; 14 Suppl I():111-7. PubMed ID: 8293762 [TBL] [Abstract][Full Text] [Related]
17. Impairment of endothelial function induced by glyc-oxidized lipoprotein a [Lp(a)]. Galle J; Winner B; Conzelmann E; Wanner C Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1035-45. PubMed ID: 9846885 [TBL] [Abstract][Full Text] [Related]
18. Co-incubation of native and oxidized low-density lipoproteins: potentiation of relaxation impairment. Perségol L; Sementa V; Athias A; Lecerf J; Lallemant C; Gambert P Eur J Pharmacol; 2000 Oct; 406(3):429-37. PubMed ID: 11040350 [TBL] [Abstract][Full Text] [Related]
19. Oxidized low-density lipoprotein inhibits endothelium-dependent vasodilation by an antioxidant-sensitive, lysophosphatidylcholine-independent mechanism. Chan H; Lougheed M; Laher I; Steinbrecher UP J Cardiovasc Pharmacol; 2003 Jun; 41(6):856-65. PubMed ID: 12775962 [TBL] [Abstract][Full Text] [Related]
20. Oxidized low-density lipoproteins inhibit endothelium-dependent relaxations in isolated large and small rabbit coronary arteries. Buckley C; Bund SJ; McTaggart F; Bruckdorfer KR; Oldham A; Jacobs M J Auton Pharmacol; 1996 Oct; 16(5):261-7. PubMed ID: 9023670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]